APR 21, 2020 1:00 PM PDT

New Diagnostic FET-based Biosensor Enables Rapid Detection of SARS-CoV-2

WRITTEN BY: Lawrence Renna

The coronavirus disease 2019 (COVID-19) pandemic continues to be at the forefront of the world’s attention. COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Currently, there is still a considerable need to develop diagnostic tests for the SARS-CoV-2 that are rapid, easy to implement, and more accurate than existing tests. New research, published on April 20, 2020, in the journal ACS Nano details the discovery of a new diagnostic test that uses a field-effect transistor (FET)-based biosensor to detect SARS-CoV-2. This new technology can detect very small concentrations of the virus (concentrations of 1 fg/mL) from samples collected from nasopharyngeal (deep nasal passage) swabs.

A majority of the currently available diagnostic tests for SARS-CoV-2 involve a technique called real-time reverse transcription-polymerase chain reaction (RT-PCR). In RT-PCR, a tiny amount of the virus’ ribonucleic acids (RNA), collected from the patient, are copied millions to billions of times in order to amplify the signal and detect the virus. Unfortunately, this ‘copying’ process typically takes at least 3 hours and requires an additional, time-consuming step to prepare the virus’ RNA for amplification. Thus, rapid detection is not currently possible.

Enter FET-based diagnostic biosensors! FETs are common electrical components used in many different integrated circuits for a variety of applications. Edmond Changkyun Park, Seung Il Kim, and colleagues developed a FET-based biosensor based on a sheet of graphene, with antibodies attached to it, that can instantly and easily detect SARS-CoV-2. Their technique does not require any additional steps to prepare the sample from the patient for testing. The FET-based diagnostic tool works by modulating the electrical signal from the device when the virus binds to the attached antibodies. Their device was highly sensitive to SARS-CoV-2 and did not show any false-positives from other similar viruses such as the Middle East respiratory syndrome-related coronavirus (MERS-CoV). This new diagnostic device would enable instant detection of SARS-CoV-2 in patients. Also, this FET-biosensor can be adapted for the easy and rapid detection of other viruses that already exist or may emerge in the future.

 

 

Sources: American Chemical Society, ACS Nano

About the Author
PhD
Hello! I am a scientist currently living in Southern California, although I am originally from the east coast. I received my B.S. in Chemistry from Northeastern University in 2012, and my Ph.D. in Chemistry from the University of Massachusetts Amherst. I also had a postdoctoral appointment at the University of California, Irvine. I have written 25+ peer-reviewed articles, several patents, and one book chapter. I am a reviewer for scientific manuscripts, and a freelance editor and writer. Outside of science, I enjoy spending time with my family, training Jiu-Jitsu, and baking sourdough bread. I am happy to be writing for LabRoots.
You May Also Like
SEP 30, 2022
Health & Medicine
Financial Incentive Influences Decision to Help for Less Empathic Individuals
SEP 30, 2022
Financial Incentive Influences Decision to Help for Less Empathic Individuals
A highly empathic person tends to help a person in need willingly, but what about those individuals with low empathy? A ...
OCT 09, 2022
Genetics & Genomics
Small Trial of Down Syndrome Treatment Sees Positive Results
OCT 09, 2022
Small Trial of Down Syndrome Treatment Sees Positive Results
Down syndrome is the most common genetic type of intellectual disability. It occurs when a person carries an extra copy ...
OCT 10, 2022
Neuroscience
Botox Can Relieve Depression & Anxiety, Now Researchers Know How
OCT 10, 2022
Botox Can Relieve Depression & Anxiety, Now Researchers Know How
Botox, or botulinum toxin, might be most popularly known as a treatment for wrinkles; it's a neurotoxic agent produced b ...
OCT 13, 2022
Cardiology
Sex Differences in Atrial Fibrillation Risk
OCT 13, 2022
Sex Differences in Atrial Fibrillation Risk
New research suggests that women have a higher risk of abnormal heart rhythm than previously thought.
OCT 25, 2022
Cancer
Study Identifies Patients at High Risk of Breast Cancer Metastasis
OCT 25, 2022
Study Identifies Patients at High Risk of Breast Cancer Metastasis
Central nervous system metastasis (mCNS) accounts for most brain and spinal cord tumors.  While recent advances hav ...
NOV 21, 2022
Immunology
Unusual, Ultrapotent Antibody Against Zika is Discovered
NOV 21, 2022
Unusual, Ultrapotent Antibody Against Zika is Discovered
Zika virus is transmitted by the Aedes aegypti mosquito and can cause a mild illness in otherwise healthy adults. But wh ...
Loading Comments...